TTK is a favorable prognostic biomarker for triple-negative breast cancer survival

PURPOSE: Previous studies demonstrate that threonine and tyrosine kinase (TTK) is overexpressed in triple-negative breast cancer (TNBC), but there are conflicting results regarding its effect on TNBC survival. The purpose of this study was to assess the prognostic significance of TTK expression in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Qianqian, Xu, Yali, Pan, Bo, Wu, Liangcai, Ren, Xinyu, Zhou, Yidong, Mao, Feng, Lin, Yan, Guan, Jinghong, Shen, Songjie, Zhang, Xiaohui, Wang, Changjun, Zhong, Ying, Zhou, Liangrui, Liang, Zhiyong, Zhao, Haitao, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348432/
https://www.ncbi.nlm.nih.gov/pubmed/27833085
http://dx.doi.org/10.18632/oncotarget.13245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348432/
https://www.ncbi.nlm.nih.gov/pubmed/27833085
http://dx.doi.org/10.18632/oncotarget.13245

Ejemplares similares